Kevin987 · Newsroom

“Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030”
A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.

April 19, 2021

Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise.
The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise.

April 19, 2021

The nuclear medicine and radiopharmaceuticals manufacturing market grow at an annualized rate of over 10%,
Roots Analysis has announced the addition of “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report to its list of offerings.

April 19, 2021

Nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics

April 19, 2021

‘Biologics Fill / Finish Service Providers, 2019-2030’
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage)

April 19, 2021

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development

April 19, 2021

Contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%,
Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 19, 2021

Contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers

April 19, 2021

“Microbial Contract Biomanufacturing Market, 2020-2030’’
A detailed review of the current landscape of companies offering contract manufacturing services for biologics

April 12, 2021

Over 115 companies, across the world, claim to offer a variety of product development
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems

April 12, 2021

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%,
Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and identifying potential future growth opportunities.

April 12, 2021

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines

April 12, 2021

Microbial contract biomanufacturing market is growing at a CAGR of 8.7%,
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies

April 12, 2021

“STING Pathway Targeting Therapeutics and Technologies, 2020-2030”
A detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters, such as type of STING modulator

April 12, 2021

Many small / macro molecule-based STING pathway modulators are currently being evaluated
In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community

April 12, 2021

The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%,
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”

April 12, 2021

STING pathway targeting technologies market, is anticipated to be worth over USD 2.8 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”

April 12, 2021

“Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030”
A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing

April 5, 2021

Over 60 companies across the globe claim to manufacture drug products (Roots Analysis)
The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing

April 5, 2021

Continuous manufacturing market is projected to grow at an annualized rate of over 15% (till 2030)
Roots Analysis has done a detailed study on Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030.

April 5, 2021

Continuous manufacturing market is estimated to be worth around USD 2 billion in 2030 (Roots Analysis)
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step

April 5, 2021

“Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
An overview of the current market landscape of digital therapeutic solutions, including information on status of development

April 5, 2021

Over 100 industry players are engaged in evaluating the potential of several prescription (Roots Analysis)
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions

April 5, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030 (Roots Analysis)
Roots Analysis has done a detailed study on Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution

April 5, 2021

Global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, (Roots Analysis)
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting

April 5, 2021

Global digital therapeutics market, growing at a CAGR of 19.7%, (Roots Analysis)
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting

April 5, 2021

“STING Pathway Targeting Therapeutics and Technologies, 2020-2030” – Roots Analysis
A detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters

April 1, 2021

Many small / macro molecule-based STING pathway modulators are currently being evaluated
In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community.

April 1, 2021

STING pathway targeting technologies market is projected to grow at an annualized rate of ~25% - till 2030
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” covering key aspects of the industry and identifying future growth opportunities.

April 1, 2021

STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics - Roots Analysis
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies

April 1, 2021

over 350 such drug candidates are being evaluated in the clinical stages of development – Roots Analysis
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration.

April 1, 2021

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030 – Roots Analysis
Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 covering key aspects of the industry and identifying future growth opportunities

April 1, 2021

Subcutaneous biologic drugs and affiliated technologies market - Roots Analysis
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals

April 1, 2021

“Companion Diagnostics Development Services Market, 2020-2030” – Roots Analysis
A detailed assessment of the current market landscape of companies offering companion diagnostics services

March 31, 2021

The globe presently claim to provide services for the development of companion diagnostic tests - Roots Analysis
It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise.

March 31, 2021

Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5% - till 2030
Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market, 2020-2030 covering key aspects of the industry and identifying future growth opportunities

March 31, 2021

Companion Diagnostics Development Services Market - Roots Analysis
In the last couple of years, a record number of personalized therapeutic products were approved in the US

March 31, 2021

“Large Volume Wearable Injectors Market (5th Edition), 2020-2030” – Roots Analysis
An overview of current market landscape of the large volume wearable injectors available for delivery of insulin and non-insulin drugs, providing information on status of development and device specifications, such as type of device

March 31, 2021

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs
The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry

March 31, 2021

The large volume wearable injectors market is projected to grow at an annualized rate of ~35% - till 2030
Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030

March 31, 2021

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030 - Roots Analysis
Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits

March 31, 2021

Microbial Contract Biomanufacturing Market, 2020-2030 – By Roots Analysis
A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment

March 30, 2021

Over 115 companies, across the world, claim to offer a variety of product development - Roots Analysis
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems,

March 30, 2021

Microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030
Over 115 companies, across the world, claim to offer a variety of product development, manufacturing and support services, for various types of biologics that are manufactured / expressed in microbial system

March 30, 2021

Microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 - Roots Analysis
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines

March 30, 2021

Microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030 - Roots Analysis
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies

March 30, 2021

Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 – Roots Analysis
A detailed assessment of the current market landscape featuring over 280 stem cell-based therapies approved

March 30, 2021

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy – By Roots Analysis
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options.

March 30, 2021

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030 - By Roots Analysis
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade

March 30, 2021